WHO ICTRP trial
An observational study to check if Azelnidipine and Telmisartan combination is…
CTRI/2025/10/095717 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/10/095717 |
|---|---|
| Public title | An observational study to check if Azelnidipine and Telmisartan combination is effective and safe in patients with high blood pressure. |
| Scientific title | Clinical Outcomes with Azelnidipine and Telmisartan Fixed-Dose Combination in Hypertensive Patients: A Real-World, retrospective Study (ACT-HTN Study) - ACT-HTN |
| Primary sponsor | Torrent Pharmaceuticals Ltd. |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Countries | India |
| Conditions | Health Condition 1: I10-I16- Hypertensive diseases |
| Interventions | Intervention1: Nil: Nil |
| Registration date | Aug 10, 2025 |
| Target size | 4000 |
| Secondary IDs | TPL2507022, Version: 00, Dated: 15/09/2025 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: